TW202334179A - 胜肽 - Google Patents

胜肽 Download PDF

Info

Publication number
TW202334179A
TW202334179A TW111137268A TW111137268A TW202334179A TW 202334179 A TW202334179 A TW 202334179A TW 111137268 A TW111137268 A TW 111137268A TW 111137268 A TW111137268 A TW 111137268A TW 202334179 A TW202334179 A TW 202334179A
Authority
TW
Taiwan
Prior art keywords
peptide
amino acid
tgf
seq
group
Prior art date
Application number
TW111137268A
Other languages
English (en)
Chinese (zh)
Inventor
鈴木芳典
杵渕政彦
Original Assignee
日商肽夢想股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商肽夢想股份有限公司 filed Critical 日商肽夢想股份有限公司
Publication of TW202334179A publication Critical patent/TW202334179A/zh

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW111137268A 2021-09-30 2022-09-30 胜肽 TW202334179A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021161353 2021-09-30
JP2021-161353 2021-09-30

Publications (1)

Publication Number Publication Date
TW202334179A true TW202334179A (zh) 2023-09-01

Family

ID=85780814

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111137268A TW202334179A (zh) 2021-09-30 2022-09-30 胜肽

Country Status (10)

Country Link
US (1) US20250034212A1 (https=)
EP (1) EP4410816A4 (https=)
JP (1) JPWO2023054712A1 (https=)
KR (1) KR20240082377A (https=)
CN (1) CN118103387A (https=)
AU (1) AU2022355276A1 (https=)
CA (1) CA3234324A1 (https=)
IL (1) IL311773A (https=)
TW (1) TW202334179A (https=)
WO (1) WO2023054712A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025070720A1 (ja) * 2023-09-29 2025-04-03 ペプチドリーム株式会社 ペプチド
TW202535907A (zh) * 2023-11-10 2025-09-16 日商肽夢想股份有限公司 胜肽、胜肽複合體、醫藥組成物、細胞培養用組成物、以及用於醫療用、診斷用或是研究用之組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240912A (en) * 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US5525491A (en) 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
WO2001066140A1 (en) 2000-03-09 2001-09-13 Genzyme Corporation Use of tgf-beta antagonists to treat or to prevent loss of renal function
BR0116024A (pt) 2000-12-07 2005-12-13 Lilly Co Eli Proteìna de fusão heteróloga e uso da mesma
EP1534737A4 (en) * 2002-04-29 2007-10-31 Univ Saint Louis PEPTIDANTAGONISTS OF MEMBERS OF THE TGF BETA FAMILY AND THEIR THERAPEUTIC APPLICATION
US8188260B2 (en) 2005-12-06 2012-05-29 The University Of Tokyo Versatile acylation catalytic RNAs and uses thereof
MY165160A (en) 2010-09-01 2018-02-28 Genzyme Corp TREATMENT OF MYOCARDIAL INFARCTION USING TGF-ß ANTAGONISTS
HRP20201384T1 (hr) 2014-01-01 2020-11-27 Medivation Technologies Llc Spojevi i postupci njihove upotrebe
US10882894B2 (en) * 2015-08-11 2021-01-05 Anie Philip Peptidic TGF-beta antagonists
JP6952747B2 (ja) 2018-09-18 2021-10-20 ファイザー・インク がん処置のためのＴＧＦβ阻害剤およびＣＤＫ阻害剤の組合せ

Also Published As

Publication number Publication date
EP4410816A1 (en) 2024-08-07
CN118103387A (zh) 2024-05-28
EP4410816A4 (en) 2025-11-19
US20250034212A1 (en) 2025-01-30
WO2023054712A1 (ja) 2023-04-06
JPWO2023054712A1 (https=) 2023-04-06
IL311773A (en) 2024-05-01
KR20240082377A (ko) 2024-06-10
AU2022355276A1 (en) 2024-05-16
CA3234324A1 (en) 2023-04-06

Similar Documents

Publication Publication Date Title
WO2021167107A1 (ja) ヒトトランスフェリンレセプター結合ペプチド
TW202334179A (zh) 胜肽
TW202304947A (zh) 胜肽及包含胜肽之組成物
TW202321274A (zh) 人類運鐵蛋白受體結合肽
TWI858016B (zh) 血球凝集素結合肽
JP7854211B2 (ja) ヘマグルチニン結合ペプチド
TW202434613A (zh) 人類運鐵蛋白受體結合肽
US20250282820A1 (en) Peptide complex having trkb binding activity
HK40105341A (zh) 人转铁蛋白受体结合肽
CN121925425A (zh) 肽
JP2024523280A (ja) Ｇｈｒ結合ペプチドおよびそれを含む組成物
WO2025047927A1 (ja) Ｖｅｇｆｒ－２アゴニスト活性を有するペプチド複合体
HK40057758B (zh) 血球凝集素结合肽
HK40105891A (zh) 人转铁蛋白受体结合抗体-肽缀合物
JP2026510340A (ja) 呼吸器合胞体ウイルス表面糖タンパク質ペプチド、コンジュゲート、及びその使用
CN117858889A (zh) 肽及包含肽的组合物
TW202305012A (zh) c-Met 蛋白質結合肽複合物
HK40057758A (en) Hemagglutinin-binding peptide
Parlak Peptide-based drug systems